Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nykode Therapeutics ASA Director's Dealing 2021

Nov 2, 2021

3695_dirs_2021-11-02_56574961-4650-469f-bfd8-1b033674c771.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

1 Details of the closely associated enterprise
a) Name Kvantia AS
2 Details of the person discharging managerial responsibilities
a) Name Christian Åbyholm
b) Position Board Member
3 Reason for notification
b) Initial notification/
Amendment
Initial
4 Details of issuer
a) Name Vaccibody AS
b) LEI 254900UKQHWYZJD22017
5 conducted Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
a) Description of the
financial instrument,
type of instrument
Shares in Vaccibody AS (ISIN: NO0010714785)
b) Nature of the
transaction
Sale of shares to closely associated enterprise
c) Price(s) and volume(s) Price(s) Volume(s)
NOK 64.00 10,866,325
d) Aggregated information Price NOK 64.00
-Average price, Volume 10,866,325
aggregated volume and
total amount
Total amount NOK 695,444,800
e) Date of the transaction 02.11.2021
f) Place of the transaction MERK – Euronext Growth Oslo
1 Details of the closely associated enterprise
a) Name Christiania Skibs AS
2 Details of the person discharging managerial responsibilities
a) Name Christian Åbyholm
b) Position Board Member
3 Reason for notification
b) Initial notification/
Amendment
Initial
4 Details of issuer
a) Name Vaccibody AS
b) LEI 254900UKQHWYZJD22017
5 conducted Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
a) Description of the
financial instrument,
type of instrument
Shares in Vaccibody AS (ISIN: NO0010714785)
b) Nature of the
transaction
Sale of shares to closely associated enterprise
c) Price(s) and volume(s) Price(s) Volume(s)
NOK 64.00 6,304,250
d) Aggregated information Price NOK 64.00
-Average price, Volume 6,304,250
aggregated volume and
total amount
Total amount NOK 403,472,000
e) Date of the transaction 02.11.2021
f) Place of the transaction MERK – Euronext Growth Oslo
1 Details of the closely associated enterprise
a) Name Victoria India Fund AS
2 Details of the person discharging managerial responsibilities
a) Name Christian Åbyholm
b) Position Board Member
3 Reason for notification
b) Initial notification/
Amendment
Initial
4 Details of issuer
a) Name Vaccibody AS
b) LEI 254900UKQHWYZJD22017
5 conducted Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
a) Description of the
financial instrument,
type of instrument
Shares in Vaccibody AS (ISIN: NO0010714785)
b) Nature of the
transaction
Acquisition of shares from closely associated enterprise
c) Price(s) and volume(s) Price(s) Volume(s)
NOK 64.00 17,170,575
d) Aggregated information Price NOK 64.00
-Average price, Volume 17,170,575
aggregated volume and
total amount
Total amount NOK 1,098,916,800
e) Date of the transaction 02.11.2021
f) Place of the transaction MERK – Euronext Growth Oslo